tiprankstipranks
Jushi Holdings (TSE:JUSH)
:JUSH

Jushi Holdings (JUSH) AI Stock Analysis

267 Followers

Top Page

TSE:JUSH

Jushi Holdings

(JUSH)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
C$0.81
▲(4.94% Upside)
Action:ReiteratedDate:12/20/25
Jushi Holdings' overall stock score reflects significant financial challenges, particularly in profitability and leverage, which are the most impactful factors. While there are positive signs in revenue growth and operational improvements, these are counterbalanced by increased net losses and valuation concerns. Technical indicators suggest a neutral market sentiment, and regulatory uncertainties add further risk.
Positive Factors
Revenue Growth
Consistent revenue growth signifies expanding market reach and product adoption, which can enhance long-term business stability and shareholder value.
Negative Factors
Net Loss Increase
Rising net losses indicate financial challenges that could hinder future investments and operational expansions, impacting long-term viability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth signifies expanding market reach and product adoption, which can enhance long-term business stability and shareholder value.
Read all positive factors

Jushi Holdings (JUSH) vs. iShares MSCI Canada ETF (EWC)

Jushi Holdings Business Overview & Revenue Model

Company Description
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pe...
How the Company Makes Money
Jushi Holdings generates revenue primarily through the sale of cannabis products in both medical and recreational markets. Key revenue streams include direct sales from retail locations, wholesale distribution to third-party dispensaries, and e-co...

Jushi Holdings Earnings Call Summary

Earnings Call Date:Mar 31, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Neutral
The call communicated clear operational progress — including meaningful yield and quality improvements, expanding adjusted EBITDA margins, targeted retail growth, and a refinancing that extends maturities without equity dilution — positioning the company to benefit from favorable regulatory developments (notably Virginia adult use). However, these positives are tempered by only modest revenue growth, full-year margin compression, a larger Q4 net loss, substantial debt and high interest costs (new 12.5% term loan), reliance on employee retention credits to boost results, and ongoing pricing pressure across markets. The balanced mix of notable operational momentum and material financial / market headwinds suggests cautious optimism but no decisive swing to a broadly positive outlook.
Positive Updates
Revenue Growth (Q4 and Full Year)
Q4 2025 revenue was $68.3M, up ~4% YoY from $65.9M; full year 2025 revenue was $262.9M, up just over 2% YoY, reflecting stabilization across the retail footprint and contributions from new stores.
Negative Updates
Modest Top-Line Growth Overall
Full-year revenue growth was only just over 2% YoY and Q4 growth was ~4% YoY, indicating top-line expansion remains modest amid competitive, price‑constrained markets.
Read all updates
Q4-2025 Updates
Negative
Revenue Growth (Q4 and Full Year)
Q4 2025 revenue was $68.3M, up ~4% YoY from $65.9M; full year 2025 revenue was $262.9M, up just over 2% YoY, reflecting stabilization across the retail footprint and contributions from new stores.
Read all positive updates
Company Guidance
The company provided clear near-term financial and operational guidance: 2026 capital expenditures are expected to be $9–13 million total (maintenance CapEx $4–5 million; growth CapEx $5–8 million), with most construction-related spending pushed into 2027 and larger Virginia build‑outs likely financed via a mortgage or expanded facility debt; Jushi also completed a $160 million first‑lien term loan (12.5% coupon, interest‑only for 36 months, due 2029) on March 27, 2026, which repaid prior term loan (~$46.1M) and second‑lien notes (~$86.2M), added about $13 million of incremental liquidity and imposes a single covenant to maintain a minimum cash balance (cash was $26.6M at 12/31/25). On regulatory timing, Virginia license applications are expected on/before September 1, 2026 with converted licenses issued on/before December 1, 2026 (a $10 million conversion fee per operator payable under an agreed plan, first payment due by December 1, 2026) and retail adult‑use sales anticipated to begin January 1, 2027; management noted prior market transitions (e.g., New Jersey) saw ~3.2x growth comparing annualized medical to the first four full quarters of adult‑use, which they would expect to be a comparable uplift for Virginia.

Jushi Holdings Financial Statement Overview

Summary
Jushi Holdings faces significant financial challenges, particularly in terms of profitability and leverage. Despite positive revenue and free cash flow growth, high debt levels and negative equity position pose substantial risks. The company needs to improve operational efficiency and reduce leverage to enhance financial stability.
Income Statement
45
Neutral
Balance Sheet
30
Negative
Cash Flow
50
Neutral
BreakdownTTMDec 2024Dec 2023Mar 2023Dec 2021Mar 2021
Income Statement
Total Revenue260.43M257.52M363.67M284.28M209.29M80.77M
Gross Profit110.77M118.30M142.49M95.48M87.37M43.07M
EBITDA37.75M50.72M40.96M-121.65M86.37M-181.90M
Net Income-65.50M-48.78M-87.87M-273.94M20.25M-211.87M
Balance Sheet
Total Assets431.70M440.32M611.03M529.34M677.91M359.28M
Cash, Cash Equivalents and Short-Term Investments23.17M19.52M38.44M26.20M94.96M93.79M
Total Debt113.05M271.13M394.04M321.20M246.09M95.07M
Total Liabilities533.17M490.56M621.08M483.45M494.82M357.53M
Stockholders Equity-101.47M-50.23M-8.22M47.28M184.48M-177.00K
Cash Flow
Free Cash Flow16.65M16.86M-18.98M-78.30M-72.74M-25.43M
Operating Cash Flow18.83M21.57M-4.48M-21.42M1.58M-3.72M
Investing Cash Flow-17.41M-7.07M0.00-80.86M-112.48M-44.73M
Financing Cash Flow1.85M-24.46M0.0033.98M120.81M95.41M

Jushi Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.77
Price Trends
50DMA
0.70
Positive
100DMA
0.73
Positive
200DMA
0.78
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
58.37
Neutral
STOCH
91.25
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JUSH, the sentiment is Positive. The current price of 0.77 is above the 20-day moving average (MA) of 0.66, above the 50-day MA of 0.70, and below the 200-day MA of 0.78, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 58.37 is Neutral, neither overbought nor oversold. The STOCH value of 91.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JUSH.

Jushi Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
C$2.25B16.236.29%6.18%-28.69%
56
Neutral
C$1.63B-13.95-9.71%4.27%3.41%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
C$2.60B-8.05-28.58%-3.38%-31.35%
48
Neutral
C$2.17B-1.75-30.10%-4.58%-141.91%
47
Neutral
C$147.78M-2.1488.51%3.17%-24.07%
45
Neutral
C$596.74M-33.00%-6.48%22.63%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:JUSH
Jushi Holdings
0.74
0.38
105.56%
TSE:CURA
Curaleaf Holdings
3.36
2.34
229.41%
TSE:GTII
Green Thumb Industries
9.70
2.49
34.54%
TSE:TRUL
Trulieve Cannabis
8.48
3.88
84.35%
TSE:CL
Cresco Labs
1.34
0.55
69.62%
TSE:VRNO
Verano Holdings
6.32
0.00
0.00%

Jushi Holdings Corporate Events

Executive/Board ChangesPrivate Placements and Financing
Jushi Holdings Amends CEO Employment Agreement to Address Capital Needs
Neutral
Dec 16, 2025
Jushi Holdings Inc. announced amendments to CEO Jim Cacioppo’s employment agreement to manage near-term working capital requirements. The amendments, approved by independent directors, involve a restructuring of Cacioppo’s compensation...
Business Operations and StrategyExecutive/Board Changes
Jushi Holdings Adjusts CEO Compensation Amid Financial Strategy Shift
Neutral
Dec 16, 2025
Jushi Holdings Inc. has amended the employment agreement of its CEO, Jim Cacioppo, to manage near-term working capital requirements. The amendments involve replacing his cash bonus and stock options with a reduced cash payment and restricted share...
Business Operations and StrategyProduct-Related Announcements
Jushi Holdings Expands Shayo Cannabis Brand to Nevada Market
Positive
Nov 12, 2025
Jushi Holdings Inc. has announced the expansion of Shayo, a cannabis-infused wellness brand co-created with Real Housewives star Stacey Rusch, into the Nevada Adult-Use Market. Following its success in Virginia’s medical market, Shayo’...
Business Operations and StrategyProduct-Related Announcements
Jushi Holdings Expands into New Jersey with Beyond Hello™ Little Ferry Dispensary
Positive
Nov 12, 2025
Jushi Holdings Inc. has announced the opening of its first dispensary in New Jersey, Beyond Hello™ Little Ferry, marking its entry into the state’s cannabis market and expanding its national retail presence to 42 locations. This new di...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Jushi Holdings Reports Strong Q3 2025 Financial Results and Strategic Expansion
Positive
Nov 4, 2025
Jushi Holdings Inc. reported a revenue of $65.7 million for the third quarter of 2025, reflecting continued growth and improved profitability. The company achieved a gross profit margin of 46.7%, driven by strategic enhancements in its grower-proc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 20, 2025